Literature DB >> 6316826

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin.

A C Steere, A R Pachner, S E Malawista.   

Abstract

Twelve patients were treated with high-dose intravenous penicillin for neurologic abnormalities of Lyme disease. Headache, stiff neck, and radicular pain usually began to subside by the second day of therapy and were often gone by 7 to 10 days. Five of the 12 patients continued to have intermittent mild headache for several more weeks, but no patient relapsed after therapy was stopped. Compared to 15 previous patients treated with prednisone alone, the duration of meningitic syndrome was significantly shorter in those given penicillin (mean duration, 1 versus 29 weeks, p less than 0.000001). However, in both groups, a mean of 7 to 8 weeks was required for complete recovery of motor deficits. Despite antibiotic therapy, 3 of the 12 patients treated with penicillin continued to have frequent arthralgias, musculoskeletal pain, and fatigue. We conclude that high-dose intravenous penicillin is effective therapy for neurologic abnormalities of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316826     DOI: 10.7326/0003-4819-99-6-767

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  58 in total

Review 1.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

2.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

Review 3.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

Review 4.  Lyme disease: a review.

Authors:  D Nathwani; N Hamlet; E Walker
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

5.  Three further cases of Lyme disease.

Authors:  D E Bateman; J E White; G Elrington; N F Lawton; M F Muhlemann; R J Greenwood
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

6.  From New to old England: the progress of Lyme disease.

Authors:  A Parke
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-28

Review 7.  Ocular Lyme disease: case report and review of the literature.

Authors:  D J Kauffmann; G P Wormser
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

8.  Neuropathy of vasculitic origin in a case of Garin-Boujadoux-Bannwarth syndrome with positive borrelia antibody response.

Authors:  F Camponovo; C Meier
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

9.  Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.

Authors:  V Preac-Mursic; B Wilske; G Schierz; E Süss; B Gross
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

10.  Persistent atrioventricular block in Lyme borreliosis.

Authors:  W Mayer; F X Kleber; B Wilske; V Preac-Mursic; W Maciejewski; H Sigl; E Holzer; W Doering
Journal:  Klin Wochenschr       Date:  1990-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.